Following an eight-year academic career at the University of Melbourne, Dr Nash transitioned to industry R&D, commencing at AMRAD in 1996. He has spent 28 years in various research and executive leadership positions and was most recently Chief Scientific Officer and Head of Research at CSL. In this role he provided overarching scientific leadership and was directly responsible for CSL’s global research activity. Throughout his career Dr Nash has championed the translation of Australian biomedical research outcomes into new therapies for unmet medical needs, led multiple projects that have transitioned into clinical programs, and contributed significantly to the development of an Australian workforce and the supporting infrastructure that is prerequisite for a successful Australian-based biopharmaceutical sector. He currently serves as a Director of the Burnet Institute, Brandon Biocatalyst and Denteric.